Collegium Pharmaceutical (COLL) EBITDA Margin Growth (1y) (2017 - 2026)
Collegium Pharmaceutical (COLL) EBITDA Margin Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Collegium Pharmaceutical | 897.54 Mn | 748.22 Mn | 110.29 Mn | -1,652.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 997.00 |
| Mar 31, 2026 | 376.00 |
| Dec 31, 2025 | -7,277.00 |
| Sep 30, 2025 | 779.00 |
| Jun 30, 2025 | -1,400.00 |
| Mar 31, 2025 | -2,194.00 |
| Dec 31, 2024 | 6,115.00 |
| Sep 30, 2024 | -1,106.00 |
| Jun 30, 2024 | 639.00 |
| Mar 31, 2024 | 1,713.00 |
| Dec 31, 2023 | 3,284.00 |
| Sep 30, 2023 | 1,681.00 |
| Jun 30, 2023 | 1,730.00 |
| Mar 31, 2023 | 2,897.00 |
| Dec 31, 2022 | 9,738.00 |
| Sep 30, 2022 | -183.00 |
| Jun 30, 2022 | -1,079.00 |
| Mar 31, 2022 | -3,612.00 |
| Dec 31, 2021 | -10,869.00 |
| Sep 30, 2021 | -684.00 |